Invest in Design Therapeutics Inc on Stash
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. The Company is focused on developing small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs), that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases. The Company’s pipeline product candidates are Friedreich ataxia and Myotonic dystrophy (CTG). Friedreich ataxia (FA) is a monogenic, autosomal recessive progressive disease. Myotonic dystrophy (DM1) is a monogenic, autosomal dominant, progressive neuromuscular disease that affects skeletal muscle, heart, brain and other organs.
Ticker: DSGN
Design Therapeutics Inc
$10.28
+2.90%
$
DSGN Performance Breakdown
Share Price
$10.28
Today's change
-0.19%
Year to date change (YTD)
12.97%
Dividend yield
0.0
Last dividend paid
N/A
Last dividend pay date
N/A
About DSGN
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. The Company is focused on developing small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs), that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases. The Company’s pipeline product candidates are Friedreich ataxia and Myotonic dystrophy (CTG). Friedreich ataxia (FA) is a monogenic, autosomal recessive progressive disease. Myotonic dystrophy (DM1) is a monogenic, autosomal dominant, progressive neuromuscular disease that affects skeletal muscle, heart, brain and other organs.
Design Therapeutics Inc Stock Ticker
DSGN
For more information
Invest in Design Therapeutics Inc on Stash
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. The Company is focused on developing small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs), that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases. The Company’s pipeline product candidates are Friedreich ataxia and Myotonic dystrophy (CTG). Friedreich ataxia (FA) is a monogenic, autosomal recessive progressive disease. Myotonic dystrophy (DM1) is a monogenic, autosomal dominant, progressive neuromuscular disease that affects skeletal muscle, heart, brain and other organs.
Certain companies are volatile
Certain companies can be volatile, meaning the stock price fluctuates significantly. Don’t put all your eggs into one basket and remember to keep the Stash Way in mind when you invest.
Design Therapeutics Inc stock news
Why invest with Stash?
Fractional shares
Thousands of stocks and ETFs. No investing minimums.
Unlimited trades
Plus no add-on trading commission fees.†
Diversification analysis
Custom investment recommendations can help you diversify.
Automatic investing
Dividend reinvestment,8 recurring investments, and more.
The Stock-Back® Card
We’ll give you matching stock in companies you shop at.1
Learn how to invest
Get professional advice and education at every step.
How to buy Design Therapeutics Inc stock on Stash
Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.
Stash offers two subscription plans: Stash Growth and Stash+.
Once your market order of Design Therapeutics Inc stock is complete, you'll officially be a shareholder of Design Therapeutics Inc!
Invest in Design Therapeutics Inc on Stash
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. The Company is focused on developing small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs), that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases. The Company’s pipeline product candidates are Friedreich ataxia and Myotonic dystrophy (CTG). Friedreich ataxia (FA) is a monogenic, autosomal recessive progressive disease. Myotonic dystrophy (DM1) is a monogenic, autosomal dominant, progressive neuromuscular disease that affects skeletal muscle, heart, brain and other organs.
